key: cord-0845693-h3zbbzui
authors: Laeyendecker, Oliver; Hsieh, Yu-Hsiang; Rothman, Richard E.; Dashler, Gaby; Kickler, Thomas; Fernandez, Reinaldo E.; Clarke, William; Patel, Eshan U.; Tobian, Aaron A.R.; Kelen, Gabor D.; Quinn, Thomas C.
title: Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department
date: 2021-04-30
journal: Am J Emerg Med
DOI: 10.1016/j.ajem.2021.04.081
sha: 5144c2b266f444678d016455ad77dd50af27e6f7
doc_id: 845693
cord_uid: h3zbbzui

BACKGROUND: Emergency Departments (EDs) have served as critical surveillance sites for infectious diseases. We sought to determine the prevalence and temporal trends of acute (by PCR) and convalescent (by antibody [Ab]) SARS-CoV-2 infection during the earliest phase of the pandemic among patients in an urban ED in Baltimore City. METHODS: We tested remnant blood samples from 3255 unique ED patients, collected between March 16th and May 31st 2020 for SARS-CoV-2 Ab. PCR for acute SARS-CoV-2 infection from nasopharyngeal swabs was obtained on any patients based on clinical suspicion. Hospital records were abstracted and factors associated with SARS-CoV-2 infection were assessed. RESULTS: Of 3255 ED patients, 8.2% (95%CI: 7.3%, 9.2%) individuals had evidence of SARS-CoV-2 infection; 155 PCR+, 78 Ab+, and 35 who were both PCR+ and Ab+. Prevalence of disease increased throughout the study period, ranging from 3.2% (95%CI: 1.8%, 5.2%) PCR+ and 0.6% (95%CI: 0.1%, 1.8%) Ab+ in March, to 6.2% (95%CI: 5.1%, 7.4%) PCR+ and 4.2% (95%CI: 3.3%, 5.3%) Ab+ in May. The highest SARS-CoV-2 prevalence was found in Hispanic individuals who made up 8.4% (95%CI: 7.4%, 9.4%) of individuals screened, but 35% (95%CI: 29%, 41%) of infections (PCR and/or Ab+). Demographic and clinical factors independently associated with acute infection included Hispanic ethnicity, loss of smell or taste, subjective fever, cough, muscle ache and fever. Factors independently associated with convalescent infection were Hispanic ethnicity and low oxygen saturation. CONCLUSIONS: The burden of COVID-19 in Baltimore City increased dramatically over the 11-week study period and was disproportionately higher among Hispanic individuals. ED-based surveillance methods are important for identifying both acute and convalescent SARS-CoV-2 infections and provides important information regarding demographic and clinical correlates of disease in the local community.

study period. For each sample, a unique study code was assigned, processed, and stored at −80°C. For all samples, basic patient demographic characteristics (age, sex, race, ethnicity, and residential zip code), clinical information (month of ED visit, COVID-19 related symptoms: loss of smell or taste, subjective fever, cough, sore throat, fatigue, diarrhea, chest pain, short of breath, muscle ache, headache, chills, and congestion) and triage vital signs (temperature, heart rate, respiratory rate, and oxygen saturation) were abstracted from medical records, and all identifiers and protected health information removed from the dataset. Laboratory testing was then performed on stored specimens after delinking the demographic/clinical dataset. The SARS-CoV-2 serostatus was merged to the demographic/clinical dataset using the unique study code. Cassette (Hangzhou Biotest Biotech Co. Ltd., Hangzhou China), a point of care test, was performed according to the manufacture's protocol with the following modification: 10ul of plasma was pipetted onto the sample well instead of whole blood [17] . Any visible band on the

CoronaChek was considered a positive result. The testing algorithm used an initial screen of the Euroimmun IgG ELISA followed by confirmatory testing of any initial indeterminate or positive result with the CoronaChek rapid test. The overall performance of this testing algorithm was 100% (24/24) sensitivity among hospitalized individuals 14 days after symptom onset; sensitivity was found to be 84% (111/133) among samples from plasma donors 50 days after positive PCR, and overall a specificity of 100% (95% CI 99.3, 100 [554/554]). Performance of serologic algorithm is presented in detail in Supplemental Methods. ED patients were tested for SARS-CoV-2 by PCR, based on presenting signs and symptoms and/or at the discretion of the treating ED clinician. With the evolving epidemic of COVID-19 and the increasing capacity of hospital SARS-CoV-2 PCR testing, the study institution granted PCR testing for ED patients with asymptomatic admission to Psychiatry or the Surgical/Procedural services in mid-April and for all asymptomatic admission patients in mid-May.

Descriptive statistical analysis was performed first including missing data which ranged from 0.1% to 2.0% for demographic or clinical characteristics out of 3255 unique patients, followed by comparison of subjects by SARS-CoV-2 PCR testing status (i.e. no evidence of infection, SARS-CoV-2 PCR+ only, and SARS-CoV-2 Ab+), and PCR and antibody status among those with evidence of infection (PCR+ only, both PCR+ and Ab+, PCR-but Ab+, and Ab+ but without PCR testing) using chi-square or Fisher's exact tests. Only PCR testing ordered in the ED were analyzed. Age was categorized into 3 groups (18-44, 45-64, and ≥65 years).

Group-specific prevalence was assessed using a composite variable of sex and race/ethnicity to categorize Hispanic female, Hispanic male, non-Hispanic white female, non-Hispanic white male, non-Hispanic Black female, non-Hispanic Black male, other female, and other male groups. Residential zip codes of subjects were categorized by the most common individual 5 zip codes (representing approximately 5% or more of the patients analyzed) and the remaining zip codes categorized as 'other'. Residential zip code was also linked to ZIP code tabulation area (ZCTA) data from the 2018 American Community Survey of 5-year estimates for proportion living below the poverty level which was categorized into <10%, 10-20%, 20-30%, ≥ 30%, or missing [18, 19] . All prevalence point estimates were presented with their corresponding 95% confidence intervals (CIs).

Associations of SARS-CoV-2 positivity with demographic and ED visit symptoms, and triage vital signs were initially performed for each variable independently using modified Poisson regression. Variables with p-value < 0.2 in the bivariate analysis were included in the multivariable regression. Month of ED visit was collapsed to 2 categories (March or April versus May) and the zip code variable was further collapsed to 3 categories (Zip Code A, B and other) with consideration of sample size in each cell. Stepwise variable selection for the multivariable regression analysis was used to select variables in the final model to estimate the adjusted prevalence ratios, adjusted for zip code clustering effects. All prevalence ratios were presented with their corresponding 95% CIs. An identical regression modeling analysis approach was employed to determine the variables associated with the presence of SARS-CoV-2 Ab. All data analyses were performed using SAS V.9.4 (SAS Institute Inc., Cary, North Carolina) and a two-J o u r n a l P r e -p r o o f sided p-value less than 0.05 was considered statistically significant. Sensitivity analysis was performed to estimate overall and age-, sex-, race-, and ethnicity-specific infection rates according to sensitivity and specificity of the serologic algorithm.

Comparisons of the proportion of cumulative patients with evidence of SARS-CoV-2 infection (SARS-CoV-2 PCR+ or Ab+) in the ED to that of the cumulative COVID-19 reported cases in Baltimore City per 1000 residents were performed by race and ethnicity (black, white, and Hispanic) every 10 days from March 31 to May 31. The ratio between two proportions for each group at each time point was also calculated. The cumulative Baltimore City COVID-19 reported case rate per 1000 residents by race and ethnicity were abstracted from Baltimore City COVID-19 Dashboard (https://coronavirus.baltimorecity.gov/).

During the 11-week study period, there were 9049 visits of 7037 unique individuals to the XXXED. There were 3830 remnant blood samples came from a total of 3255 unique individuals. Of these 3255 individuals, 55% (1798/3255) were tested for SARS-CoV-2 by PCR at their first ED visit, among whom 5.8% (190/1798) were positive. The overall seroprevalence for antibodies to SARS-CoV-2 at the first ED visit was 3.5% ( Table 1 ).

The frequency of SARS-CoV-2 infection, as assessed by either PCR+ and/or Ab+, increased from 3.6% in March to 9.1% in May. The prevalence of SARS-CoV-2 seropositivity was lower than PCR positivity over the duration of the study ( Figure 1A observed for Black women and men. In contrast, the prevalence in White women and men did not significantly change over the study period. Sensitivity analysis based on the performance of serologic algorithm found that the overall infection rate was 11.2% (95% CI: 10.1%, 12.2%). Zip codes associated with high poverty rates were not significantly associated with increased disease prevalence. Demographic-specific infection rates by the sensitivity analysis are presented in Supplemental Table 2 .

Having a fever was observed in only 3.3% (110/3255) of the population entering the XXXED over the study period, but was present in 35% ( 

One of the distinct strengths of our study from other serosurveys is that we were able to use SARS-CoV-2 PCR testing data to track active infections and to detect disparities or patterns in clinical presentations. In this large urban ED patient serosurvey conducted from mid-March to May 2020, the overall SARS-CoV-2 seroprevalence was 3.5%; during that same time period selective PCR testing found a positivity rate of 5.8%. SARS-CoV-2 seroprevalence increased from 0.6% in March to 4.2% in May, while the prevalence of PCR+ individuals rose from 3.2% to 6.2%. This rise in infection observed in the ED over 11 weeks paralleled rise in acute SARS-CoV-2 infection which was reported in Baltimore City. Notably, the detailed demographic analysis from our ED revealed early on that the burden of SARS-CoV-2 was disproportionately higher among Hispanic individuals than individuals with other ethnicity, and was the single strongest predictor of being either PCR+ or Ab+ for SARS-CoV-2. These findings corroborated the disproportional burden of SARS-CoV-2 which has been observed in the Hispanic population in other studies in the United States [20] [21] [22] [23] . In those studies, which also demonstrated a higher burden of disease among minority populations, the authors attributed the high infection to be due to social inequities, including living in high density multi-generational households and employment in 'essential' labor as one's means of income. These early observations, contributed to informing varied focused educational interventions for clinicians regarding testing and care, including developing improved outpatient services for those populations at highest risk [24] .

Unlike other serologic surveys conducted in the U.S., this ED-based study found that PCR+ individuals for SARS-CoV-2 infection outnumbered Ab+ individuals. The ratio of PCR+ to Ab+ individuals ranged from 4.7:1 to 1.5:1 over the observed study period which is notably higher than the 1:10 ratio seen in other serosurveys performed in the United States during the J o u r n a l P r e -p r o o f Journal Pre-proof same study period [25] . The ED population represents a distinctive group for carrying out infectious diseases epidemiologic and clinical research, given the fact that these are individuals who are seeking care for acute illnesses, and in some cases for primary health care, while serosurveys conducted in other settings, typically have represented asymptomatic communitybased populations [7, 11, 26] . The access to ED patients who are acutely ill as well as those who were previously infected provides a unique window into the frequency of an infection in the community, which we believe will be helpful to temporally track trends associated with various waves of pandemic, and could thus be helpful to understand the impact of local and regional interventions. Further, our identity unlinked testing method permits detailed collection of paired clinical and demographic data helpful for contextualizing the associated characteristics of those who are actively infected, and/or have been infected. These data can be revealing for example with regard to chronic effects of the disease, such as long term respiratory (i.e. persistent hypoxemia) or cardiac complications [27] , which were detected in our study as well. As the pandemic and the long term consequences of SARS-CoV-2 infections are uncovered, the ED will likely be an important site both for characterizing the prevalence of those complications and developing effective methods for intervening.

In general, signs and symptoms obtained at triage for SARS-CoV-2 were not a precise indicator of acute SARS-CoV-2 infection. The great majority of patients who had symptoms (including loss of smell or taste, fever, cough, sore throat, or shortness of breath) or signs (elevated temperature, reparations, or decreased oxygen saturation) did not have any evidence of SARS-CoV-2 infection. One intriguing finding from our study was the statistically increased prevalence of low oxygen saturation present in convalescent seropositive patients. This is suggestive of the pronounced chronic effects following COVID-19 in many people, and is of growing concern given the potential ongoing medical utilizations needs over time associated with this disease [28, 29] . Given that the ED has, and will likely continue to serve as a common site of follow-up for SARS-CoV-2 patients who are initially diagnosed in the ED (particularly those who are marginalized or at increased risk for not receiving primary care services) further research to corroborate and explain this observation is needed.

With increasing number of Americans who have received at least 1 dose of COVID-19 vaccine [30] , future serosurveys of SARS-CoV-2 infection that use conventional SARS-CoV-2 antibody assays will not truly reflect prevalence of current or past infection in the community, J o u r n a l P r e -p r o o f Journal Pre-proof unless more complicated specialized serologic assays that can differentiate natural and vaccineinduced immunity are performed [31] . On the other hand, our study presents an ED-based active surveillance model that uses PCR-based testing data for active infection surveillance in order to provide rapid public health responses in given vulnerable resource-limited communities, especially during the time when more individuals have received COVID-19 vaccine. With active infection surveillance data at hand, EDs could partner with local health departments and community-based organizations to prioritize targeted geographical testing, contact tracing, and vaccine distribution without stigmatizing or targeting racial, ethnic, or other groups [32] [33] [34] .

There are a number of limitations to our study. First, the population that was screened is composed of ED patients and therefore highly enriched for symptomatic individuals. Second, antibody testing was only performed on 46% of all individuals attending the XXXED during the study period, as samples were limited only to those individuals who required a blood draw for CBC testing. Third, only 55% of the subjects tested for antibody had been tested for acute SARS-CoV-2 at their ED visit. Fourth, the ability to detect the neighborhood effects of local hotspots and poverty level on SARS-CoV-2 infection in the multivariate regression model is somewhat limited due to the use of zip code-level data in the model rather than census block data which could provide more granular neighborhood data. However, census block data were not available. Similarly, we were not able to identify the difference between mono-lingual Spanish/indigenous Latino patients and bilingual patients within the heterogeneous Latinx community in Baltimore since language information was not collected in this study. Fifth, the sensitivity of the serologic algorithm was less than 100%, although the specificity was 100%. This is consistent with most other serologic studies in which the sensitivity of antibody tests among non-hospitalized patients has been demonstrated to be approximately 85%. This lower sensitivity is due to the finding that a proportion of non-hospitalized individuals fail to make an antibody response to SAR-CoV-2 infection [35] . Finally, the sensitivity of PCR on nasopharyngeal samples is at best 80% for symptomatic individuals three to five days post infection, and drops significantly after that time [36] . Together these results indicate that the burden of SARS-CoV-2 infection would be underestimated in ours or any surveillance study which uses this algorithm. By using both PCR and serologic assays for antibody, one can however estimate longitudinal epidemiologic patterns within a particular population. 

A Novel Coronavirus from Patients with Pneumonia in China

Timeline: WHO's COVID-19 response

Developing a National Strategy for

Antibody Testing) in the United States

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers

Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity

Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward

Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area

SARS-CoV-2 Seroprevalence among

First Response, and Public Safety Personnel

Seroprevalence of SARS-CoV-2 Among

Frontline Health Care Personnel in a Multistate Hospital Network -13 Academic Medical Centers

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study

Unsuspected human immunodeficiency virus in critically ill emergency patients

Parallel declines in HIV and hepatitis C virus prevalence, but not in herpes simplex virus type 2 infection: A 10-year, serial cross-sectional study in an inner-city emergency department

Global surveillance of emerging Influenza virus genotypes by mass spectrometry

Racial/ethnic disparities in COVID-19 disease burden & mortality among emergency department patients in a safety net health system

Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department

Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing

Zip code tabulation areas (ZCTA)

American Community Survey 5 year estimates, tables B03002, S1701, and B01003

Risk Factors for Testing Positive for SARS-CoV-2 in a National US Healthcare System

Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study

Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population

SARS-CoV-2 Positivity Rate for Latinos in the Baltimore-Washington, DC Region

Lessons We've Learned -Covid-19 and the Undocumented 26

Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults

Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

The lasting misery of coronavirus long-haulers

As Their Numbers Grow, COVID-19 "Long Haulers" Stump Experts

County-Level COVID-19 Vaccination Coverage and Social Vulnerability -United States

Centers for Disease Control and Prevention (CDC). Interim Guidelines

Antibody Testing -Interim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings

Emergency Department Visits for COVID-19 by Race and Ethnicity -13 States

Vaccination: Where Do We Stand?

Vaccine Delivery: Findings from the Johns Hopkins Hospital Emergency Department

The authors have no conflicts of interest to declare.

Supplementary maerial